Peptonic Medical AB (publ) (“Peptonic” or “the Company”) is expanding its product portfolio in the intimate health category and launching VagiVital Intimate V Wipes, intimate wipes specially developed for gentle cleansing of the external areas of the intimate region. The launch is part of Peptonic’s strategy to develop VagiVital into a stronger and broader brand in intimate care, with products for a variety of everyday needs.
The launch is a strategically important step in Peptonic’s ambition to develop VagiVital into a leading and comprehensive brand in intimate self-care, with products that meet women’s needs throughout all phases and situations of life.
With VagiVital Intimate V Wipes, Peptonic is expanding its offering from treatment and moisturizing products to include practical premium products for daily intimate care and an active lifestyle.
“We are very pleased to be able to expand our range with VagiVital Intimate V Wipes—a product that has been requested by our customers and that complements our existing portfolio in a natural and strategic way. Our vision is to establish VagiVital as the obvious first choice in intimate self-care, with innovative products that combine quality, safety, and user-friendliness,” says Daniel Rudeklint, interim CEO of Peptonic Medical AB.
VagiVital Intimate V Wipes are exclusively developed for external intimate care and contain glycerin to moisturize the skin, as well as a pre- and probiotic complex that helps support the skin’s natural balance. The product leaves the skin clean, fresh, and soft while contributing to a pleasant sense of comfort and well-being.
The launch strengthens Peptonic’s position in modern intimate self-care and is a step toward making intimate care more accessible, less stigmatized, and integrated into women’s daily lives.
Intimate V Wipes are scheduled to launch in the second half of 2026.
For further information, please contact:
Daniel Rudeklint, Interim CEO, Peptonic Medical AB
Email: daniel.rudeklint@peptonicmedical.se
Phone: +46 73 158 02 73
About Peptonic Medical AB
Peptonic Medical AB (publ) is a Swedish medical technology company that develops and sells clinically proven self-care products for women’s intimate health. Under the VagiVital and Vernivia brands, the Company offers an over-the-counter portfolio of effective and gentle products that help women understand, treat, and prevent common gynecological conditions. Peptonic’s growth strategy is based on geographic expansion, particularly in the U.S. and Europe, and on continuously strengthening the product portfolio through in-house product development and strategic acquisitions.
The Company is headquartered in Stockholm, Sweden, and has subsidiaries Peptonic Medical Inc. and Common Sense Marketing Inc. in the U.S. Peptonic Medical was founded in 2009 and has been listed on the Spotlight Stock Market since 2014.
